All issues > Volume 53(3); 2010

Review Article

Korean J Pediatr. 2010;53(3):294-299. Published online March 15, 2010.

Clinical application of gonadotropin-releasing hormone analogs in children and adolescents

Ho-Seong HS Kim¹

¹Department of Pediatrics, College of Medicine, Yonsei University, Seoul, Korea

Correspondence Ho-Seong HS Kim ,Email: kimho@yuhs.ac

Received: February 18, 2010;  Accepted: February 22, 2010.

Abstract

Although the increasing incidence of central precocious puberty (CPP) in Korea has recently raised public concerns about health and growth problems, there are many areas of uncertainty regarding the pathogenesis, diagnosis, and management of CPP. In this paper, we review the definition of precocity, the assessment of CPP, and the hormonal abnormalities that support the diagnosis. In addition, we review the practical guidelines regarding the clinical use of gonadotropin-releasing hormone analogs in children with CPP. Indications for treatment, determination of dosage, monitoring during treatment, and discontinuation of therapy are discussed.

Keywords :Central precocious puberty, Gonadotropin-releasing hormone analogs